Open Philanthropy recommended a grant of $796,878 over five years to the International AIDS Vaccine Initiative to support additional sputum sample collection as part of a Phase IIb trial of MTBVAC, a novel tuberculosis vaccine. This sample collection will enable testing to assess the vaccine’s effect on incidence of subclinical tuberculosis cases, as well as provide valuable information on the incidence of subclinical tuberculosis in the wider study population.
This falls within our focus area of global health R&D.